Answers are grounded in this paper and cite their sources.
Background: This study aimed to investigate the effects of various anesthetic agents—dexmedetomidine, desflurane, sevoflurane, and propofol—on the expression levels of selected microRNAs (miRNAs) (miR-27b-3p, -155-5p, -148b-3p, and -223-3p) in cerebrospinal fluid (CSF) and plasma samples obtained from adult neurosurgical patients with intracranial meningioma. Methods: We analyzed 37 patients undergoing intracranial meningioma resection. MiRNA expression levels in paired CSF and venous blood samples were assessed at three predefined intraoperative time points: T1: Baseline samples (peripheral venous blood and lumbar CSF) collected after anesthesia induction but prior to skin incision. T2: Intraoperative samples obtained following dural opening, immediately preceding tumor resection. T3: Final samples acquired after complete tumor removal and wound closure. Patients were stratified into four groups according to the anesthetic regimen administered. MiRNA quantification was performed via reverse transcription followed by real-time polymerase chain reaction, with subsequent statistical analysis. Results: Temporal profiling of miRNA expression revealed a statistically significant alteration in miR-148b-3p levels following dexmedetomidine administration. This effect was observed exclusively in CSF samples between time points T1–T2 and T1–T3, with no corresponding changes detected in plasma. Furthermore, our findings did not support the hypothesis that CSF miRNA expression patterns correlate with those in plasma. Conclusions: Our findings demonstrate that dexmedetomidine modulates the expression of miR-148b-3p; given the established roles of this miRNA in the literature, this regulation might contribute to the known neuroprotective properties of the drug.
No takes yet. Share an insight, caveat, or question.
Petrova et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: